SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-19-009537
Filing Date
2019-12-13
Accepted
2019-12-13 16:00:49
Documents
5
Period of Report
2020-01-16
Effectiveness Date
2019-12-13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tnxp-def14a_011620.htm DEF 14A 1078888
2 GRAPHIC proxycard001.jpg GRAPHIC 1064
3 GRAPHIC proxycard002.jpg GRAPHIC 2883
4 GRAPHIC proxycard003.jpg GRAPHIC 2208
5 GRAPHIC proxycard004.jpg GRAPHIC 3120
  Complete submission text file 0001387131-19-009537.txt   1093370
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 191284588
SIC: 2834 Pharmaceutical Preparations